Vanguard Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 7.66 Cr
as on 03-07-2024
- Company Age 38 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 14.65 Cr
as on 03-07-2024
- Revenue 15.95%
(FY 2023)
- Profit 70.27%
(FY 2023)
- Ebitda 60.66%
(FY 2023)
- Net Worth 13.45%
(FY 2023)
- Total Assets 23.25%
(FY 2023)
About Vanguard Therapeutics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 7.66 Cr.
The company has closed loans amounting to ₹14.65 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Potineni Swetha, Potineni Rani, and Potineni Rao serve as directors at the Company.
- CIN/LLPIN
U70102TG1986PTC006360
- Company No.
006360
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Andhra Pradesh, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vanguard Therapeutics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Potineni Rao  | Managing Director | 07-Apr-1986 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Potineni Swetha | Director | 01-Aug-2022 | Current |
| Potineni Rani | Director | 05-Feb-1991 | Current |
Financial Performance of Vanguard Therapeutics.
Vanguard Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.95% increase. The company also saw a substantial improvement in profitability, with a 70.27% increase in profit. The company's net worth Soared by an impressive increase of 13.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vanguard Therapeutics?
In 2023, Vanguard Therapeutics had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vassar Labs It Solutions Private LimitedActive 10 years 4 monthsPotineni Rani and Potineni Rao are mutual person
Vindhya Agricultural Farms Private LimitedActive 28 years 2 monthsPotineni Rani and Potineni Rao are mutual person
- Vindhya Vahini Food Processing Private LimitedActive 10 years 11 months
Potineni Rani and Potineni Rao are mutual person
- Swathi Greenfields Private LimitedActive 10 years 11 months
Potineni Rani and Potineni Rao are mutual person
Charges (Loans)
₹0
₹14.65 Cr
Charges Breakdown by Lending Institutions
- 3I Infotech Trusteeship Services Limited : 5.00 Cr
- Hdfc Bank Limited : 4.95 Cr
- Icici Bank Ltd : 3.75 Cr
- Karnataka Bank Ltd : 0.80 Cr
- The Karnataka Bank Ltd : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Nov 2013 | Hdfc Bank Limited | ₹4.95 Cr | Satisfied |
| 07 Feb 2008 | 3I Infotech Trusteeship Services Limited | ₹5.00 Cr | Satisfied |
| 31 Dec 2004 | Icici Bank Ltd | ₹3.75 Cr | Satisfied |
| 02 Mar 2002 | The Karnataka Bank Ltd | ₹1.50 M | Satisfied |
| 15 Sep 1998 | Karnataka Bank Ltd | ₹6.00 M | Satisfied |
How Many Employees Work at Vanguard Therapeutics?
Vanguard Therapeutics has a workforce of 2 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vanguard Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanguard Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
